Articlenpj drug discovery2026

RUNX2 inhibitor CADD522 improves bone microarchitecture and lipid metabolism in post-menopausal bone loss.

Adel Ersek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.